About INFLAMMANOVA RX LLC
InflammaNova Rx is a biotechnology company focused on developing STING protein inhibitors for neuroinflammatory and neurodegenerative diseases such as Parkinson's, Alzheimer's, ALS, and long COVID-19. The company leverages human cell-based research and disease modeling to advance its drug candidates.
Development of STING protein inhibitorsHuman cell-based discovery and validationDisease modeling for neuroinflammatory disordersIn silico 3D modeling of protein interactionsBlood-brain barrier permeability testing
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to INFLAMMANOVA RX LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.